Holen Sie sich die Stockscreener-App
23.46
1.76%
-0.42
Handel nachbörslich:
23.92
0.46
+1.96%
Stoke Therapeutics Inc Aktie (STOK) Neueste Nachrichten
Jacobs Levy Equity Management Inc. Purchases New Stake in Stoke Therapeutics, Inc. $STOK - MarketBeat
Siren L.L.C. Buys 247,347 Shares of Stoke Therapeutics, Inc. $STOK - MarketBeat
Stoke Therapeutics (NASDAQ:STOK) Sets New 52-Week HighWhat's Next? - MarketBeat
Invesco Ltd. Has $174,000 Stock Position in Stoke Therapeutics, Inc. $STOK - MarketBeat
Stoke Therapeutics (NASDAQ:STOK) Trading Down 5.4%Time to Sell? - MarketBeat
Granahan Investment Management LLC Buys 92,741 Shares of Stoke Therapeutics, Inc. $STOK - MarketBeat
Stoke Therapeutics (STOK) Unveils Promising Data For Dravet Syndrome Drug - Yahoo Finance
Checkpoint Capital L.P. Increases Stake in Stoke Therapeutics, Inc. $STOK - MarketBeat
Stoke Therapeutics, Inc. $STOK Shares Sold by Trexquant Investment LP - MarketBeat
Russell Investments Group Ltd. Purchases New Stake in Stoke Therapeutics, Inc. $STOK - MarketBeat
What is Stoke Therapeutics Inc.’s valuation compared to sectorShare Buyback & Community Consensus Picks - Lancaster City Council
What’s the analyst consensus on Stoke Therapeutics Inc.New Guidance & Verified Stock Trade Ideas - beatles.ru
Insider Selling: Stoke Therapeutics (NASDAQ:STOK) General Counsel Sells 6,345 Shares of Stock - MarketBeat
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress - Placera.se
Stoke Therapeutics (NASDAQ:STOK) Reaches New 52-Week HighWhat's Next? - MarketBeat
Stoke Therapeutics stock reaches 52-week high at 20.5 USD By Investing.com - Investing.com Australia
108,087 Shares in Stoke Therapeutics, Inc. $STOK Bought by Nuveen LLC - MarketBeat
Will Stoke Therapeutics Inc. outperform its industry peersJuly 2025 Summary & Stepwise Trade Signal Guides - خودرو بانک
Stoke Therapeutics and the Potential of Zorevunersen in Redefining Dravet Syndrome Treatment - AInvest
Is Stoke Therapeutics Inc. part of any major indexQuarterly Market Review & Fast Moving Stock Trade Plans - خودرو بانک
Why is Stoke Therapeutics Inc. stock going upMarket Growth Review & Technical Entry and Exit Tips - خودرو بانک
Will breakout in Stoke Therapeutics Inc. lead to full recoveryJuly 2025 Recap & High Accuracy Investment Entry Signals - Newser
Is Stoke Therapeutics Inc. still worth holding after the dipRisk Management & Technical Pattern Based Buy Signals - Newser
Volume spikes in Stoke Therapeutics Inc. stock – what they mean2025 Trading Volume Trends & AI Driven Stock Price Forecasts - Newser
Analyzing drawdowns of Stoke Therapeutics Inc. with statistical tools2025 Geopolitical Influence & Low Risk Entry Point Tips - Newser
Published on: 2025-09-05 21:40:33 - خودرو بانک
Stoke Therapeutics stock reaches 52-week high at 20.5 USD - Investing.com
Price action breakdown for Stoke Therapeutics Inc.July 2025 Institutional & High Win Rate Trade Tips - Newser
Key metrics from Stoke Therapeutics Inc.’s quarterly data2025 Momentum Check & Expert Verified Movement Alerts - Newser
Applying Wyckoff theory to Stoke Therapeutics Inc. stock2025 Market Overview & Fast Moving Trade Plans - Newser
Relative strength of Stoke Therapeutics Inc. in sector analysisTrade Entry Summary & Entry Point Strategy Guides - Newser
Sector ETF performance correlation with Stoke Therapeutics Inc.Market Rally & Low Drawdown Investment Ideas - Newser
Charles Schwab Investment Management Inc. Sells 31,822 Shares of Stoke Therapeutics, Inc. $STOK - MarketBeat
Market reaction to Stoke Therapeutics Inc.’s recent newsWeekly Gains Report & Entry Point Strategy Guides - Newser
How to use Fibonacci retracement on Stoke Therapeutics Inc.Bull Run & Free Safe Entry Trade Signal Reports - Newser
A | Is Stoke Therapeutics, Inc. a turnaround storyQuarterly Growth Report & Daily Risk Controlled Trade Plans - خودرو بانک
Can volume confirm reversal in Stoke Therapeutics Inc.Weekly Market Outlook & Precise Buy Zone Tips - Newser
What does recent volatility data suggest for Stoke Therapeutics Inc.Portfolio Update Report & Low Risk Investment Opportunities - Newser
Stoke Therapeutics Inc. recovery potential after sell off2025 Market Overview & Risk Managed Investment Entry Signals - Newser
Will Stoke Therapeutics Inc. bounce back from current supportQuarterly Profit Review & Short-Term High Return Ideas - Newser
Insider Sell: Kaye Edward M. MD Sells 61,885 Shares of Stoke The - GuruFocus
Will Stoke Therapeutics Inc. stock go up in YEARJuly 2025 Drop Watch & Consistent Profit Trading Strategies - خودرو بانک
DAFNA Capital Management LLC Buys 272,901 Shares of Stoke Therapeutics, Inc. $STOK - MarketBeat
Institutional scanner results for Stoke Therapeutics Inc.2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - Newser
Building trade automation scripts for Stoke Therapeutics Inc.Bull Run & Technical Confirmation Trade Alerts - Newser
Stoke Therapeutics' Insider Sales: A Cautionary Tale or a Sign of Strength? - AInvest
Assessing Insider Selling Trends at Stoke Therapeutics (STOK): Liquidity Moves or Loss of Confidence? - AInvest
Stoke Therapeutics Executives Buy and Sell Shares in August and September 2025. - AInvest
Will Stoke Therapeutics Inc. benefit from rate cutsQuarterly Profit Summary & Free Technical Confirmation Trade Alerts - خودرو بانک
What analysts say about Stoke Therapeutics Inc. stockJuly 2025 Sentiment & Precise Swing Trade Entry Alerts - خودرو بانک
Stoke Therapeutics shares fall 2.40% premarket after presenting data from Phase 1/2a and open-label extension studies of zorevunersen. - AInvest
Can a trend reversal in Stoke Therapeutics Inc. lead to recoveryIndex Update & Risk Controlled Swing Trade Alerts - Newser
Siren L.L.C. Has $14.95 Million Position in Stoke Therapeutics, Inc. $STOK - MarketBeat
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):